Osterweis Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-103,614
Closed -$6.45M 207
2023
Q4
$6.45M Buy
103,614
+42,439
+69% +$2.37M 0.41% 67
2023
Q3
$3.43M Buy
+61,175
New +$3.44M 0.25% 83
2021
Q1
Sell
-159,505
Closed -$7.96M 143
2020
Q4
$7.96M Buy
159,505
+28,500
+22% +$1.34M 0.47% 61
2020
Q3
$6.69M Buy
131,005
+3,350
+3% +$140K 0.45% 59
2020
Q2
$4.48M Sell
127,655
-42,930
-25% -$1.48M 0.32% 74
2020
Q1
$4.33M Buy
+170,585
New +$5.07M 0.35% 62

Other funds holding AXNX

Osterweis Capital Management's AXNX Position: Q1 2024 in Review

Osterweis Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 103,614 shares — an estimated $6.45M sold.

Osterweis Capital Management first reported a position in AXNX in Q1 2020 and held it in 6 quarters. The position peaked at $7.96M in Q4 2020. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Osterweis Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Osterweis Capital Management sold 103,614 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $6.45M.
  • Osterweis Capital Management first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
  • Osterweis Capital Management's Axonics, Inc. Common Stock position peaked at $7.96M in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Osterweis Capital Management's 13F filing for Q1 2024, filed 15 May 2024.